Be Efficient By Nature

Cyntegrity (origin: clinical + integrity), an innovative company inspired by efficiency, provides a specialized cloud solution for the risk-based monitoring (RBM).

Our mission is to offer trial management tools that are more predictive than retrospective. They integrate the knowledge from previous trials with contextual, real-world data to reduce patient-risk and to optimize preventive care.

Risked-based Monitoring Solutions

Our RBM.Cloud builds up a “nervous system” of a clinical trial. It guarantees early risk identification by providing a centralized location where risk data are saved, managed, monitored, and reported.

icon-risk-assessment

@RACT

Risk Assessment and Categorization Tool

@RACT

@RACT® – the first free cloud version of Risk Assessment and Categorization Tool, originally developed by TransCelerate Group and improved further by Cyntegrity in cooperation with PPH plus. Register today for free!

learn more
icon-risk-based-monitoring

What is RBM

Risk-based Monitoring

What is RBM

Risk-based Monitoring (RBM) is becoming an essential concept in pharmaceutical clinical research today.
Which has potential to reduce clinical costs and improve data quality, and time-to-market of a medicine.

learn more
icon-early-bird - RBM.cloud

RBM.cloud

Detect, Manage, Mitigate

RBM.cloud

Detect, Manage, Mitigate
Together with the application EarlyBird® Cyntegrity conducts total risk management of a clinical trial. It analyses data driven KRIs, builds reports and Risk-based Monitoring dashboard.

learn more

 

 Recent Posts

RBM: innovation or just common sense?

November 24, 2016|0 Comments

The article covers the topics of clinical trial budgeting when applying the risk-based monitoring [...]

The Emergence of a “Risk Monitor”: Preparing for the future.

November 9, 2016|0 Comments

Pharmaceutical companies and contract research organizations (CROs) are increasingly trying to leverage technology to optimize [...]

FDA Guidance – Oversight of Clinical Investigations an RBM Approach to Monitoring (Infographic)

October 26, 2016|0 Comments

Click here for downloading the PDF version. Based on the source: http://www.fda.gov/downloads/Drugs/.../Guidances/UCM269919.pdf

Latest News

ICH Finalized GCP Addendum E6 Revision 2

November 18, 2016|0 Comments

The ICH GCP Addendum E6 R(2) is final now! Global good clinical practice (GCP) [...]

WHO Guideline on Good Data and Record Management Practices is Final

November 9, 2016|0 Comments

The WHO guideline on Good Data and Record Management practices is now final, below you [...]

Andy Lawton, a leader in TransCelerate’s RBM initiative joins Cyntegrity

September 22, 2016|0 Comments

Andy Lawton, a top expert with 35+ years of experience in clinical trials in the [...]

Cyntegrity’s RBM Platform “EarlyBird” offers a variety of useful components to support Risk Based Monitoring. I’m looking forward to the first Implementation in one of our next studies.
Steffen Koenig, President at DGGF e.V. (German Society for Good Research Practice), General Manager at IST GmbH
Cyntegrity’s @RACT is not just a cloud-based version of RACT. It is a comprehensive system that follows a solid risk management process. @RACT reinforces that process with in-depth analysis tools to support real-time decision making at both the study and enterprise levels.
Keith Morgenstern, Director Metrics Programs Metrics Champion Consortium
Great that Cyntegrity offers a tool that operationlizes the TransCelerate RACT tool; even better that this enables through a common platform the sharing of risk assessments what will be key to quality risk management as we should learn from IATA!
Beat E. Widler PhD ETH-Z, Managing Partner Widler & Schiemann Ltd.
I think you developed already a great tool, at least from the look and feel point of view. I have no idea how cumbersome the implementation is, how much programming is required etc. I can also imagine that coming to an agreement on what is a risk and the definition for it probably takes most of the time.
Dr. Johann Proeve, Global Development and Strategy Advisor in Global Data Sciences and Analytics at Bayer HealthCare